120
B. E. Fulloon and C. Wentrup
Methyl N-(4-Fluorophenyl)ketenimine-1-carboxylate 11b
Acknowledgement
νmax/cm−1 2953, 2047 (C=C=N), 1721 (C=O), 1506, 1443,
1234, 1149, 1040. δH (CDCl3) 3.71 (s, 3H, CH3), 4.61 (s, 1H),
7.03–7.32 (m, 4H). δC (CDCl3) 51.83 (OCH3), 52.83, 116.65
(d), 126.44 (d), 132.47, 162.42 (C–F, d, J 249.5), 168.41 (C=O),
177.15 (N=C). m/z (EIMS) 193 (M+), 162, 134, 107, 95, 75,
57. HRMS calc. for C10H8NO2F 193.0539. Found 193.0549.
The present work was supported by the Australian Research Council.
References
[1] (a)V.Andriole,TheQuinolones2000(AcademicPress:NewYork, NY).
(b) Fluoroquinolone Antibiotics (Eds A. R. Ronald, D. E. Low) 2003
(Birkhäuser: Basel).
[2] L. M. Jarvis, Chem. Eng. News 2008, 86, 15.
[3] H. Bibas, D. W. J. Moloney, R. Neumann, M. Shtaiwi, P. V. Bernhardt,
C. Wentrup, J. Org. Chem. 2002, 67, 2619. doi:10.1021/JO0110552
[4] (a)V.V. Ramana Rao, C. Wentrup, J. Chem. Soc., PerkinTrans. 1 1998,
2583. doi:10.1039/A802768D
(b) D. Clarke, R. W. Mares, H. McNab, J. Chem Soc., Perkin Trans. 1
1997, 1799. doi:10.1039/A700421D
[5] V. V. Ramana Rao, C. Wentrup, J. Chem. Soc., Perkin Trans. 1 2002,
1232. doi:10.1039/B202128E
Methyl N-(2,3,4-Trifluorophenyl)ketenimine-
1-carboxylate 11c
νmax/cm−1 2954, 2046 (C=C=N), 1725 (C=O), 1515, 1440,
1246, 1155, 1013. δH (CDCl3) 3.72 (s, 3H, CH3), 4.67 (s, 1H),
6.93–7.12 (m, 2H). δC (CDCl3) 51.99 (OCH3), 52.50, 111.99
(m), 120.67 (m), 122.05, 140.50 (C–F, dt, J 251.5), 146.23 (C–
F, ddd, J 226.3), 151.83 (C–F, ddd, J 220.2), 167.81 (C=O),
181.77 (N=C). m/z (EIMS) 229 (M+), 198, 170, 143, 123, 99,
75. HRMS calc. for C10H6NO2F3 229.0351. Found 229.0334.
[6] (a) C. Wentrup, V. V. Ramana Rao, W. Frank, B. F. Fulloon,
D. W. J. Moloney, T. Mosandl, J. Org. Chem. 1999, 64, 3608.
doi:10.1021/JO982471Y
(b) L. George, M. W. Wong, C. Wentrup, Org. Biomol. Chem. 2007,
5, 1437. doi:10.1039/B702518A
[7] (a) J. J. Finnerty, C. Wentrup, J. Org. Chem. 2004, 69, 1909.
doi:10.1021/JO035419X
(b) J. J. Finnerty, C. Wentrup, J. Org. Chem. 2005, 70, 9735.
doi:10.1021/JO051389H
[8] B. E. Fulloon, C. Wentrup, J. Org. Chem. 1996, 61, 1363.
doi:10.1021/JO951832W
[9] R. Koch,T. Bruhn, R. N.Veedu, C. Wentrup, J. Mol. Struct.Theochem.
2004, 686, 31. doi:10.1016/J.THEOCHEM.2004.07.027
[10] (a) P. V. Bernhardt, R. Koch, D. W. Moloney, M. Shtaiwi, C. Wentrup,
J. Chem. Soc., Perkin Trans. 2 2002, 515. doi:10.1039/B109624A
(b) R. N. Veedu, P. V. Bernhardt, R. Koch, C. Wentrup, Aust. J. Chem.
2008, 61, 805. doi:10.1071/CH08277
[11] (a) S.-C. Kuo, H.-Z. Lee, J.-P. Juang, Y.-T. Lin, T.-S. Wu, J.-J. Chang,
D. Lednicer, K. D. Paull, C. M. Lin, J. Med. Chem. 1993, 36, 1146.
doi:10.1021/JM00061A005
Methyl 6-Fluoroindole-3-carboxylate 15a
This compound is commercially available and has been synthe-
sized by Kleeman et al.[19] Mp 194–196◦C. δH (CDCl3) 3.89
(s, 3H, OCH3), 7.01 (ddd, 1H, H-5, J5,7 2.3, J5,F 8.8), 7.07 (dd,
1H, H-7, J7,F 9.1), 7.87 (d, 1H, H-2), 8.09 (dd, 1H, H-4, J4,5 9.0,
J4,F 5.4), 8.61 (bs, 1H, NH). δC (CDCl3) 51.14 (OCH3), 98.02
(d), 109.11, 110.94 (d), 122.29, 122.60 (d), 131.16, 136.02 (d),
160.34 (C–F, d, J 240.0), 165.26 (C=O). νmax(KBr)/cm−1 3247,
2947, 1669, 1531, 1143, 1282, 1196, 1141, 1101, 1055, 954. m/z
(EIMS) 193 (M+), 162, 134, 107, 81, 57, 39. (Found: C 62.08,
H 4.14, N 7.25. Calc. for C10H8NO2F: C 62.16, H 4.18,
N 7.25%.)
Methyl 5-Fluoroindole-3-carboxylate 15b
(b) C. W. Haigh, M. H. Palmer, B. Semple, J. Chem. Soc. 1965, 6004.
doi:10.1039/JR9650006004
(c) P. A. Claret, A. G. Osbourne, Spectrosc. Lett. 1976, 9, 167.
doi:10.1080/00387017608067425
This compound is commercially available and has been synthe-
sized by Karabelas et al.[20] Mp 200–202◦C. δH (CDCl3) 3.90
(s, 3H, OCH3), 7.01 (ddd, 1H, H-6, J4,6 2.1, J6,F 9.0, J6,7 8.5),
7.31 (dd, 1H, H-4, J4,6 2.1, J4,F 10.1), 7.82 (dd, 1H, H-7, J6,7 8.5,
J7,F 5.3), 7.93 (d, 1H, H-2), 8.55 (bs, 1H, NH). δC (CDCl3) 50.94
(OCH3), 106.70 (d, J3,F 4.9), 109.01 (d, J6,F 24.0), 111.60 (d, J4,F
26.4), 112.01(d, J7,F 10.1), 126.35(d, J3a,F 11.3), 131.97, 132.23,
159.11 (C–F, d, J5,F 237.7), 165.00 (C=O). νmax(KBr)/cm−1
3229, 2948, 1674, 1527, 1446, 1364, 1276, 1196, 1148, 1038,
931. m/z (EIMS) 193 (M+), 162, 134, 107, 81, 57, 39. (Found:
C 62.06, H 4.10, N 6.99. Calc. for C10H8NO2F: C 62.16, H 4.18,
N 7.25%.)
(d) D. Doddrell, M. Barfield, W. Adcock, M. Aurangzed, D. Jordan, J.
Chem. Soc., Perkin Trans. 2 1976, 402. doi:10.1039/P29760000402
(e) L. Ernst, S. Kang, J. Chem. Res. (M) 1981, 3019.
[12] (a) D. C. England, J. Org. Chem. 1981, 46, 153. doi:10.1021/
JO00314A033
(b) D. C. England, J. Org. Chem. 1984, 49, 4007. doi:10.1021/
JO00195A025
[13] (a) C. Wentrup, R. Blanch, H. Briehl, G. Gross, J. Am. Chem. Soc.
1988, 110, 1874. doi:10.1021/JA00214A034
(b) C. Addicott, C. Wentrup, Aust. J. Chem. 2008, 61, 592.
doi:10.1071/CH08252
[14] F. C. Ye, B.-C. Chen, X. Huang, Synthesis 1989, 317. doi:10.1055/
S-1989-27241
[15] S. T. Abu-Orabi, M. A. Atfah, F. M. Mari’I, A. A. Ali, J. Heterocycl.
Chem. 1989, 26, 1461.
[16] (a) E. Leyva, D. Munoz, M. S. Platz, J. Org. Chem. 1989, 54, 5938.
doi:10.1021/JO00286A028
Methyl 5,6,7-Trifluoroindole-3-carboxylate 15c
Mp 219–222◦C. δH (CDCl3) 3.90 (s, 3H, OCH3), 7.74 (t, 1H),
7.92 (d, 1H, H-2), 8.78 (bs, 1H, NH). δC (CDCl3) 50.87 (OCH3),
95.71, 102.81 (m), 109.53 (d), 120.77 (d), 128.33 (C–F, dt, J
242.5), 131.65, 136.25 (C–F, ddd, J 239.3), 147.29 (C–F, ddd,
J 230.0), 164.11 (C=O). νmax(KBr)/cm−1 3260, 2948, 1697,
1673, 1602, 1545, 1473, 1392, 1330, 1205, 1163, 1081, 1005,
967, 918. m/z (EIMS) 229 (M+), 198, 170, 143, 123, 99, 75,
69. (Found: C 52.21, H 2.58, N 6.12. Calc. for C10H6NO2F3:
C 52.39, H 2.64, N 6.11%.)
(b) A. R. Katritzky, H. J. Keogh, S. Ohlenrott, R. D. Topsom, J. Am.
Chem. Soc. 1970, 92, 6856.
[17] (a) G. Molteni, A. Ponti, Chem. Eur. J. 2003, 9, 2770.
doi:10.1002/CHEM.200204681
(b) G. Molteni, A. Ponti, Arkivoc 2006, xvi, 49.
[18] G. Bosher, L. K. Dyall, P. R. Sadler, Aust. J. Chem. 1972, 25, 599.
[19] H.-W. Kleeman, J.-C. Carry, P. Desmazeau, S. Mignani, J. Bouquerel,
A. Genevois-Borella, B. Ronan, Aventis Pharma GMBH, PCT Int.
Appl. WO2004007480, 22 January 2004.
[20] K. Karabelas, M. Lepisto, P. Sjo, A. B. Astrazeneca, PCT 2000, SE00,
WO0071537.
IR spectra of the products of FVT of 8a–c and 13a–c at vari-
ous temperatures (Figs S1–S7) are available from the journal’s
website.